Chang-Claude J - Search Results

1

Genistein and enterolactone in relation to Ki-67 expression and HER2 status in postmenopausal breast cancer patients.

Jaskulski S, Jung AY, Rudolph A, Johnson T, Thöne K, Herpel E, Sinn P, Chang-Claude J. Jaskulski S, et al. Mol Nutr Food Res. 2017 Nov;61(11). doi: 10.1002/mnfr.201700449. Epub 2017 Sep 1. Mol Nutr Food Res. 2017. PMID: 28734033

2

Plasma enterolactone and genistein and the risk of premenopausal breast cancer.

Piller R, Chang-Claude J, Linseisen J. Piller R, et al. Eur J Cancer Prev. 2006 Jun;15(3):225-32. doi: 10.1097/01.cej.0000197449.56862.75. Eur J Cancer Prev. 2006. PMID: 16679865

3

CYP17 genotype modifies the association between lignan supply and premenopausal breast cancer risk in humans.

Piller R, Verla-Tebit E, Wang-Gohrke S, Linseisen J, Chang-Claude J. Piller R, et al. J Nutr. 2006 Jun;136(6):1596-603. doi: 10.1093/jn/136.6.1596. J Nutr. 2006. PMID: 16702327 Free article.

4

Dietary vitamin D and calcium intake and premenopausal breast cancer risk in a German case-control study.

Abbas S, Linseisen J, Chang-Claude J. Abbas S, et al. Nutr Cancer. 2007;59(1):54-61. doi: 10.1080/01635580701390223. Nutr Cancer. 2007. PMID: 17927502

5

Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer--results of a large case-control study.

Abbas S, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, Flesch-Janys D, Chang-Claude J. Abbas S, et al. Carcinogenesis. 2008 Jan;29(1):93-9. doi: 10.1093/carcin/bgm240. Epub 2007 Oct 31. Carcinogenesis. 2008. PMID: 17974532

6

Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk.

Abbas S, Nieters A, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, Flesch-Janys D, Chang-Claude J. Abbas S, et al. Breast Cancer Res. 2008;10(2):R31. doi: 10.1186/bcr1994. Epub 2008 Apr 17. Breast Cancer Res. 2008. PMID: 18419802 Free PMC article.

7

Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy.

Flesch-Janys D, Slanger T, Mutschelknauss E, Kropp S, Obi N, Vettorazzi E, Braendle W, Bastert G, Hentschel S, Berger J, Chang-Claude J. Flesch-Janys D, et al. Int J Cancer. 2008 Aug 15;123(4):933-41. doi: 10.1002/ijc.23655. Int J Cancer. 2008. PMID: 18506692

8

The Gc2 allele of the vitamin D binding protein is associated with a decreased postmenopausal breast cancer risk, independent of the vitamin D status.

Abbas S, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, Flesch-Janys D, Chang-Claude J. Abbas S, et al. Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1339-43. doi: 10.1158/1055-9965.EPI-08-0162. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18559548

9

Plasma 25-hydroxyvitamin D and premenopausal breast cancer risk in a German case-control study.

Abbas S, Chang-Claude J, Linseisen J. Abbas S, et al. Int J Cancer. 2009 Jan 1;124(1):250-5. doi: 10.1002/ijc.23904. Int J Cancer. 2009. PMID: 18839430

10

Menopausal hormone therapy and risk of clinical breast cancer subtypes.

Slanger TE, Chang-Claude JC, Obi N, Kropp S, Berger J, Vettorazzi E, Braendle W, Bastert G, Hentschel S, Flesch-Janys D. Slanger TE, et al. Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1188-96. doi: 10.1158/1055-9965.EPI-09-0002. Epub 2009 Mar 31. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19336542

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

944 results

Search Page

Filters